UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
Amendment No. 2
ACV AUCTIONS INC.
(Name of Subject Company (Issuer))
APPLE MERGER SUB, INC.
(Offeror)
A Wholly Owned Subsidiary of
COPART, INC.
(Parent of Offeror)
(Names of Filing Persons (identifying status as offeror, issuer or other person))
Common Stock,... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 29, 2026
(Exact name of Registrant as Specified in Its Charter)
Delaware
... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Rule 14a-101)
INFORMATION REQUIRED IN
PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
More SEC Filings
View Older Stories-
Form NRSRO-UPD A.M. Best Rating Service
-
Form 8-K Evommune, Inc. For: Oct 01
-
Form 8-K Strategy Inc For: Sep 30
-
Form 424B5 Antelope Enterprise Hold
-
Form 8-K RADNOSTIX INC For: Sep 28
-
Form FWP Hashdex Nasdaq CME Crypt Filed by: Hashdex Nasdaq CME Crypto Index ETF
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Guse Kyle
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Sims Andrew John Hugh MacIntyre
-
Form 6-K SILICOM LTD. For: Oct 01
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: HEDRICK MARC H
-
Form 8-K Allarity Therapeutics, For: Sep 30
-
Form 6-K Antelope Enterprise Hold For: Oct 01
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: van Es-Johansson An
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Hawkins Richard J
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: ANDREWS RONALD ASBURY
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Clowes Howard
-
Form 6-K Radiopharm Theranostics For: Oct 01
-
Form 8-K NEKTAR THERAPEUTICS For: Oct 01
-
Form 8-K USA Rare Earth, Inc. For: Oct 01
-
Form 425 Armada Acquisition Corp. Filed by: Armada Acquisition Corp. II
-
Form 4 FILANA THERAPEUTICS, For: Sep 29 Filed by: Barry Richard
-
Form 4 Uxin Ltd For: Sep 30 Filed by: Dai Kun
-
Form 8-K Armada Acquisition Corp. For: Sep 30
-
Form 8-K Veritone, Inc. For: Sep 30
-
Form 6-K POWERBANK Corp For: Oct 01
-
Form 8-K Toast, Inc. For: Sep 28
-
Form 8-K Brightline Interactive, For: Oct 01
-
Form 8-K Valion Bio, Inc. For: Sep 30
-
Form 8-K Vylor Inc. For: Oct 01
-
Form 144 ORAMED PHARMACEUTICALS Filed by: Gabay Avraham
-
Form 8-K EIDP, Inc. For: Oct 01 Filed by: Corteva, Inc.
-
Form 144 ORAMED PHARMACEUTICALS Filed by: Hexter Joshua
-
Form 8-K Monte Rosa Therapeutics, For: Oct 01
-
Form SC TO-I/A Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp
-
Form F-X TSUKISHIMA HOLDINGS CO., Filed by: Mitsubishi Kakoki Kaisha, Ltd.
-
Form 424B3 SCHMID Group N.V.
-
Form 8-K Installed Building Produ For: Oct 01
-
Form 424B3 SCHMID Group N.V.
-
Form 8-K MCCORMICK & CO INC For: Oct 01
-
Form 1-SA RSE Collection, LLC For: Jun 30
-
Form 8-K CHESAPEAKE UTILITIES For: Sep 30
-
Form 8-K CIVISTA BANCSHARES, INC. For: Oct 01
-
Form 8-K FrontView REIT, Inc. For: Oct 01
-
Form 8-K KYNTRA BIO, INC. For: Sep 30
-
Form 3/A CRH PUBLIC LTD CO For: Jul 01 Filed by: Will W Anthony
-
Form 40-17G Bitwise Funds Trust
-
Form 424B3 SCHMID Group N.V.
-
Form 424B3 SCHMID Group N.V.
-
Form 10-12G/A Third Point Private Capi
-
Form CERT T. Rowe Price Exchange-T

